Couple's Nasal Spray Trial Aims to Slow Alzheimer's Progress

A couple is participating in a groundbreaking study where Joe Walsh, who has Alzheimer's, receives an experimental nasal spray containing a monoclonal antibody aimed at reducing brain inflammation, a promising approach that could slow disease progression. The treatment has shown to decrease inflammation in Walsh's brain, and further research is planned to assess its impact on cognitive function.